Tags

Type your tag names separated by a space and hit enter

Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination?
Arch Gynecol Obstet. 2013 Mar; 287(3):571-5.AG

Abstract

OBJECTIVE

To compare the efficacy of letrozole with clomiphene citrate for ovarian stimulation prior to intrauterine insemination.

METHODS

A total of 272 patients underwent 362 cycles of stimulation prior to IUI from January 2009 to May 2011. One hundred and twenty-six patients (170 cycles) received letrozole 5 mg and 146 patients (192 cycles) received clomiphene citrate 100 mg for 5 days starting on day 3 of the cycle. Intrauterine insemination was done 36 ± 4 h after hCG injection in 99 patients (131 cycles) in the letrozole group and 115 patients (136 cycles) in the clomiphene group. The number of mature follicles and serum E2 levels was monitored on the day of hCG. Endometrial thickness was noted on the day of hCG and IUI as well. The pregnancy rate, the miscarriage rate, and other parameters were evaluated only for patients who underwent IUI.

RESULTS

The mean number of mature follicles was significantly more in the clomiphene group (1.66 ± 1.69 vs. 1.41 ± 1.53) than in the letrozole group. No significant difference in endometrial thickness on the day of hCG administration was found; however, endometrial thickness was statistically significantly higher in the clomiphene group on the day of IUI (9.28 ± 1.43 vs. 8.77 ± 1.34). Serum E(2) levels on the day of hCG were statistically significantly higher in the clomiphene group (501.09 ± 2.45 vs. 214.79 ± 2.43 pg/ml). Pregnancy rate was 9.2 %/cycle and 12.12 %/patient in the letrozole group, and 8.1 %/cycle and 9.5 %/cycle in the clomiphene group; these differences were not statistically significant.

CONCLUSION

This study found no superiority of letrozole over clomiphene when used for ovarian stimulation and IUI.

Authors+Show Affiliations

Department of Obstetrics and Gynaecology, IVF and Reproductive Biology Centre, Maulana Azad Medical College, New Delhi 110002, India. shalinijotin@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article

Language

eng

PubMed ID

23053313

Citation

Khanna, Shalini C., et al. "Is Letrozole Superior to Clomiphene for Ovarian Stimulation Prior to Intrauterine Insemination?" Archives of Gynecology and Obstetrics, vol. 287, no. 3, 2013, pp. 571-5.
Khanna SC, Kumar A, Joy SG, et al. Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination? Arch Gynecol Obstet. 2013;287(3):571-5.
Khanna, S. C., Kumar, A., Joy, S. G., Tanwar, R., Sharma, S., & Prasad, S. (2013). Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination? Archives of Gynecology and Obstetrics, 287(3), 571-5. https://doi.org/10.1007/s00404-012-2579-9
Khanna SC, et al. Is Letrozole Superior to Clomiphene for Ovarian Stimulation Prior to Intrauterine Insemination. Arch Gynecol Obstet. 2013;287(3):571-5. PubMed PMID: 23053313.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination? AU - Khanna,Shalini C, AU - Kumar,Ashok, AU - Joy,Susan G, AU - Tanwar,Renu, AU - Sharma,Shashi, AU - Prasad,Sudha, Y1 - 2012/10/05/ PY - 2012/05/20/received PY - 2012/09/20/accepted PY - 2012/10/12/entrez PY - 2012/10/12/pubmed PY - 2013/8/8/medline SP - 571 EP - 5 JF - Archives of gynecology and obstetrics JO - Arch. Gynecol. Obstet. VL - 287 IS - 3 N2 - OBJECTIVE: To compare the efficacy of letrozole with clomiphene citrate for ovarian stimulation prior to intrauterine insemination. METHODS: A total of 272 patients underwent 362 cycles of stimulation prior to IUI from January 2009 to May 2011. One hundred and twenty-six patients (170 cycles) received letrozole 5 mg and 146 patients (192 cycles) received clomiphene citrate 100 mg for 5 days starting on day 3 of the cycle. Intrauterine insemination was done 36 ± 4 h after hCG injection in 99 patients (131 cycles) in the letrozole group and 115 patients (136 cycles) in the clomiphene group. The number of mature follicles and serum E2 levels was monitored on the day of hCG. Endometrial thickness was noted on the day of hCG and IUI as well. The pregnancy rate, the miscarriage rate, and other parameters were evaluated only for patients who underwent IUI. RESULTS: The mean number of mature follicles was significantly more in the clomiphene group (1.66 ± 1.69 vs. 1.41 ± 1.53) than in the letrozole group. No significant difference in endometrial thickness on the day of hCG administration was found; however, endometrial thickness was statistically significantly higher in the clomiphene group on the day of IUI (9.28 ± 1.43 vs. 8.77 ± 1.34). Serum E(2) levels on the day of hCG were statistically significantly higher in the clomiphene group (501.09 ± 2.45 vs. 214.79 ± 2.43 pg/ml). Pregnancy rate was 9.2 %/cycle and 12.12 %/patient in the letrozole group, and 8.1 %/cycle and 9.5 %/cycle in the clomiphene group; these differences were not statistically significant. CONCLUSION: This study found no superiority of letrozole over clomiphene when used for ovarian stimulation and IUI. SN - 1432-0711 UR - https://www.unboundmedicine.com/medline/citation/23053313/Is_letrozole_superior_to_clomiphene_for_ovarian_stimulation_prior_to_intrauterine_insemination L2 - https://dx.doi.org/10.1007/s00404-012-2579-9 DB - PRIME DP - Unbound Medicine ER -